Russell J. Mumper, Ph.D.
John A. McNeill Distinguished ProfessorDr. Russell J. Mumper is currently the John A. McNeill Distinguished Professor in the Division of Molecular Pharmaceutics in the UNC Eshelman School of Pharmacy, and the first Director of the Center for Nanotechnology in Drug Delivery at UNC. Dr. Mumper’s research program focuses on nano- based delivery systems for cancer and vaccines, drug-polymer conjugates, and (trans) mucosal drug, microbicide, and vaccine delivery. From 1999-2007, Dr. Mumper was a faculty member in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Kentucky. Dr. Mumper was also the Associate Director of the Center for Pharmaceutical Science & Technology (CPST), a unique university-based fully-integrated FDA-registered GMP pharmaceutical manufacturing facility. Dr. Mumper held various product development positions in the pharmaceutical/biotech industry working for Burroughs-Wellcome Co. in North Carolina, as well as GeneMedicine, Inc. and Virotex Corporation, both in The Woodlands, Texas. Since returning to academia in 1999, Dr. Mumper has received over 50 contracts from industry and 30 grants from federal or foundation funding sources totaling over $14 million. Dr. Mumper has more than 215 scientific publications/abstracts and 38 patents or patents pending. In 2006, he received the AAPS Lipid-based Drug Delivery Award sponsored by Gattefossé Corporation and the American Association of Pharmaceutical Scientists (AAPS). In 2009, Dr. Mumper was elected a Fellow of the AAPS. Dr. Mumper has co-founded five companies based on technologies developed in his laboratories.
Last Updated on Wednesday, 09 March 2011 14:28